Excess Mortality due to natural causes among whites and blacks during the COVID-19 pandemic in Brazil

Data de publicação

2022

Periódico

Revista da Sociedade Brasileira de Medicina Tropical

Resumo

Introduction – Excess Mortality by all causes considers deaths directly related to COVID-19 and those attributed to conditions caused by the pandemic. When stratified by social dimensions, such as race/color, it allows for the evaluation of more vulnerable populations. The study estimated the excess mortality by natural causes, separating the white and black populations in 2020.

Methods – Public civil registration data on deaths observed in 2020, corrected for under registration, were used. The expected number of deaths was estimated based on the mortality rates observed in 2019, applied to the estimated population in 2020. The difference between the values expected and observed and the proportion of excess was considered the excess mortality.

Results – The present study found an excess of 270,321 deaths (22.2% above the expected) in 2020. Every state of Brazil reported deaths above the corresponding expected figure. The excess was higher for men (25.2%) than for women (19.0%). Blacks showed an excess of 27.8%, as compared to whites at 17.6%. In both sexes and all age groups, excess was higher in the black population, especially in the South, Southeast, and Midwest regions. São Paulo, the largest in population number, had twice as much excess death in the black population (25.1%) than in the white population (11.5%).

Conclusions – The present study showed racial disparities in excess mortality during the COVID-19 pandemic in Brazil. The higher excess found for the black suggests an intrinsic relationship with the socioeconomic situation, further exposing the Brazilian reality, in which social and structural inequality is evident.

DOI/link

https://doi.org/10.1590/0037-8682-0283-2021

Autoria

Vínculo institucional

Lattes

Orcid

Renato Azeredo Teixeira

Universidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Saúde Pública, Belo Horizonte, MG, Brasil; Vital Strategies, New York, United States of America.

Ana Maria Nogales Vasconcelos

Universidade de Brasília, Departamento de Estatística, Brasília, DF, Brasil.

Ana Torens

Vital Strategies, New York, United States of America.

Elisabeth Barboza França

Universidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Saúde Pública, Belo Horizonte, MG, Brasil.

Lenice Ishitani

Universidade Federal de Minas Gerais, Grupo de Pesquisas em Epidemiologia e Avaliação em Saúde, Belo Horizonte, MG, Brasil.

Ana Luiza Bierrenbach

Hospital Sírio-Libanês, Instituto de Ensino e Pesquisa, São Paulo, SP, Brasil.

Daisy Maria Xavier de Abreu

Universidade Federal de Minas Gerais, Grupo de Pesquisas em Epidemiologia e Avaliação em Saúde, Belo Horizonte, MG, Brasil.

Fátima Marinho

Vital Strategies, New York, United States of America.